Bright Minds Biosciences Files 6-K, Incorporates F-3 Registration

Ticker: DRUG · Form: 6-K · Filed: Mar 5, 2025 · CIK: 1827401

Sentiment: neutral

Topics: filing, registration, F-3

TL;DR

Bright Minds Biosciences filed a 6-K on March 5th, linking to their Feb 5th F-3 registration. Keep an eye on potential stock moves.

AI Summary

Bright Minds Biosciences Inc. filed a Form 6-K on March 5, 2025, incorporating a news release dated March 4, 2025. This filing is related to their registration statement on Form F-3 (File No. 333-284694), originally filed on February 5, 2025. The company is in the Pharmaceutical Preparations sector.

Why It Matters

This filing indicates ongoing activity and compliance related to the company's previously filed registration statement, which is crucial for potential future stock offerings or capital raises.

Risk Assessment

Risk Level: low — This is a routine filing that incorporates previously disclosed information and does not introduce new material events or financial changes.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose is to report information that Bright Minds Biosciences Inc. has made or is required to make public in Canada or the United States, specifically incorporating a news release dated March 4, 2025, by reference into their Form F-3 registration statement.

When was the Form F-3 registration statement originally filed?

The Form F-3 registration statement (File No. 333-284694) was originally filed on February 5, 2025.

What is the SIC code for Bright Minds Biosciences Inc.?

The Standard Industrial Classification (SIC) code for Bright Minds Biosciences Inc. is 2834, which corresponds to Pharmaceutical Preparations.

What is the business address of Bright Minds Biosciences Inc.?

The business address is 19 Vestry Street, New York, NY 10013.

Does Bright Minds Biosciences Inc. file annual reports under Form 20-F or 40-F?

Bright Minds Biosciences Inc. files annual reports under Form 20-F, as indicated by the checkmark next to 'Form 20-F'.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on March 5, 2025 regarding BRIGHT MINDS BIOSCIENCES INC. (DRUG).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing